Excerpts

A two-tailed paired t test revealed this difference to be highly significant ( P < 0.001).

For high-level interest, baseline-to-exit changes were highly significant for all options (at p < .001) except “going to medical school,” “a job in science education/K–12,” “a career in dentistry,” and “an allied health career.” Those with the highest degree of significant change were “scientific research (generally)” (16.8% increase), “an academic career” (14.8% increase), and “doing a Ph.D. in a scientific field” (14.4% increase).

The total effect of Reciprocity on Intention was highly significant ( β = .35, p < .001), demonstrating that Reciprocity exerts both direct and indirect influences.

The analysis revealed a highly significant effect of treatment on aphid reduction ( p < 0.001).

The correlation between the two variables is highly significant ( r = 0.43, P < 0.001).

The impact of distance to cell towers remains highly significant ( P <.001).

The SE slopes for low, moderate, and high astigmatism groups were −0.567D/y, −0.529 D/y, and −0.442 D/y, respectively, showing a decreasing trend with increasing astigmatism magnitude ( p < 0.001).

All differences were highly significant (p < 0.001), with large t values supporting robust group separation (Table 1 ).

Also, 84% of the patients who got admitted in critically sick condition hailed from rural area, while only 16% of the population comprised urban society, which again turned out to be a highly significant value ( P < 0.001) on statistical analysis.

(1981) evaluated subjects after 4 hours, 14 hours and 7 days and reported improvement rates of 40%, 38% and 65% respectively. Escobar & Barron (1983), Dubin et al. (1985), Nishikawa & Tsudo (1985), Neto et al. (1988), Coryell & Kelly (1990) and Volavka (1992) have also reported significant improvement rates of 65%, 73%, 70%, 55% and 67% respectively after 7 days in the high dose group. In the present study too, patients in the high dose group showed highly significant improvement (p<.001) from the baseline at all the evaluations.

Both LREEs/HREEs and Eu/Eu* displayed extremely significant and positive correlations with La N /Yb N , La N /Sm N , and Gd N /Yb N ( p < 0.001), respectively.

They demonstrate that the differencesob- served in A and B (total neurite length and axonal length) be- tween pAntp and controls are highly significant (p < 0.001, n = 150), whereas pAntp has no significant effect on den- drite length or soma surface area.

When the data are analyzed without including the cluster of 11gold particles in the MOPC 21 sample, the difference between MOPC 21 and a-actinin is highly significant (P < .001).

The diabetic groups treated either with insulin or REO showed a highly significant decrease in the level of serum urea (insulin: 37.32± 10.05 mg/dl, REO: 3.1± 1.03 mg/dl, p < 0.001) and a significant decrease in the level of uric acid (insulin: 3.1± 1.23 mg/dl, REO: 4.03± 1.76 mg/dl, p < 0.05) when compared with the diabetic untreated group.

Similarly, median ESR was elevated in the anaemic PJI group (58 mm/h (IQR 46 to 68)) compared with the non-anaemic group (40 mm/h (IQR 24 to 50)), demonstrating a highly significant difference (p < 0.001, Mann-Whitney U test).

When compared with the control 3A3 cell mono- layer, the effectof DCC expression on stimulation of neurite outgrowth was highly significant (P < 0.001).

The reduction in CSR is highly significant for all three genotypes (P < 0.001).

Regarding elongation at break, higher values were obtained for non-crosslinked scaffolds versus crosslinked scaffolds and weaker values obtained for the collagen reference compared to coll/chit blends in general were shown to be statistically highly significant ( p ≤ 0.001).

In the patient group, there was a moderately significant negative relationship between SMMT score and age (p<0.001, r=-0.437), neutrophil count (p=0.033, r=-0.240), CRP (p<0.001, r=-0.451), and IBI (p<0.001, r=-0.538).

By contrast, the association of sRNAs and heterochromatic DNA methylation was highly significant ( p = 0.001).

In the teplizumab group, M120 decreased over 6 months (11.6 [1.5] to 11.3 [1.5]; P = 0.036) to reveal a highly significant difference between the teplizumab and placebo groups ( P < 0.001).

We observed highly significant differences (p < 0.001) in the presence of solid components and the proportion of microcysts between the malignant and non-malignant lesion groups.

However, the CCA models of CAs 1 to 3 were highly significant ( p = 0.001), and the axes were significant, except for built-up areas ( p = 0.107).

Kaplan–Meier survival analysis showed a trend consistent with the survival results of the DNA methylation model associated with TCD (Log‐rank test p < 0.001, Figure 4G , right).

Repeated‐measures analysis results represented in Table 2 showed a highly significant decline in pain scores over time in both arms (time effect P < 0.001), with mean VAS falling from 4.33 ± 0.97 to 2.68 ± 0.81 to 1.53 ± 0.68 in the bupivacaine group and from 4.85 ± 1.05 to 3.16 ± 0.95 to 1.84 ± 0.71 in controls.